Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Feb 26, 2026
Open Peer Review Period: Mar 19, 2026 - May 14, 2026
Date Accepted: Apr 10, 2026
(currently open for review)

The final, peer-reviewed published version of this preprint can be found here:

Backcasting the Trust Gap: A Strategic Road Map for Clinician Adoption of AI Diagnostics by 2040

Yu Y

Backcasting the Trust Gap: A Strategic Road Map for Clinician Adoption of AI Diagnostics by 2040

J Med Internet Res 2026;28:e94234

DOI: 10.2196/94234

PMID: 42061228

Backcasting the Trust Gap: A Strategic Roadmap for Clinician Adoption of AI Diagnostics by 2040

  • Yunguo Yu

ABSTRACT

Background:

The integration of artificial intelligence (AI) into clinical medicine presents a persistent paradox: diagnostic models routinely demonstrate benchmark superiority over human experts, yet bedside adoption remains fragile and clinician trust is low. Conventional forecasting approaches—projecting model performance along optimistic trend lines—are epistemologically insufficient because they cannot account for the non-linear socio-technical transitions that separate technical capability from institutional trust.

Objective:

This Viewpoint applies Backcasting, a normative futures methodology with a four-decade evidence base in energy policy and public governance, to the specific challenge of clinician adoption of AI diagnostics, with the aim of identifying the structural interventions required to achieve durable trust by 2040.

Methods:

Consistent with the tradition of single-expert normative foresight analysis, we applied Backcasting as a structured reasoning framework using a STEEP (Social, Technological, Economic, Environmental, Political) analysis. Sources from PubMed, IEEE Xplore, Google Scholar, and policy repositories (FDA, WHO, OECD, European Commission) published between 2010 and 2025 were reviewed; barriers and enablers were coded across STEEP dimensions to identify Pivot Points representing convergent, time-bound structural changes.

Results:

Working backward from a defined 2040 Vision State—a health care ecosystem with risk-stratified clinician trust thresholds, semantic transparency of AI outputs, integrated AI governance, and Futures Literacy in medical education—we identified three temporal Pivot Points: (1) the 2030 standardization of Dual-Process AI Architectures, in which Large Language Models are verified in real time by locally deployed Small Language Models (SLMs) producing a Calibrated Confidence Score; (2) the 2035 institutionalization of agentic AI orchestration governed by a formally designated Chief AI Officer (CAIO); and (3) the 2040 integration of Futures Literacy and Human-AI Teaming competencies into standard medical curricula.

Conclusions:

The AI trust gap is an institutional design problem, not a technical inevitability. Backcasting reframes the central question from "when will AI be ready for medicine?" to "what must we build to make medicine ready for AI?" The three Pivot Points identified here—Verifiable AI by 2030, agentic governance by 2035, and Futures Literacy by 2040—are structural commitments that clinicians, health system leaders, and policymakers can begin building today.


 Citation

Please cite as:

Yu Y

Backcasting the Trust Gap: A Strategic Road Map for Clinician Adoption of AI Diagnostics by 2040

J Med Internet Res 2026;28:e94234

DOI: 10.2196/94234

PMID: 42061228

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.